Five Best Practices for Life Sciences Companies
Virtually all bio-pharma companies today see in- and out-licensing of their intellectual property as an essential component of their growth strategy. This white paper explores several factors and safeguards that when addressed early-on will help to streamline and secure the process, minimize risk, maintain harmony inside the company and maximize the value of each licensing deal.